Literature DB >> 135809

Mitogen-stimulated glutaraldehyde-fixed spleen cells: ability to stimulate in the mixed lymphocyte reaction and generate effector cells in cell-mediated lympholysis.

J J Lightbody, Y M Kong.   

Abstract

Mouse spleen cells treated with glutaralde lose their stimulating ability in the MLR. If the spleen cells are first converted to a blastogenic state by lipopolysaccharide and subsequently fixed with glutaraldehyde, their stimulating capacity is maintained.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 135809

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Resistance to metabolic inactivation is a functional phenotype of radioresistant stimulating spleen cells (RSCs) in allo-CTL generation.

Authors:  T Reme; C Cognot; A Dupuy d'Angeac
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

2.  Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s).

Authors:  D W Talmage; J A Woolnough; H Hemmingsen; L Lopez; K J Lafferty
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

3.  The effect of glutaraldehyde fixation on the immunogenicity of allogeneic lymphoid and tumour cells.

Authors:  J D Milton
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

4.  Suppression of lymphocyte proliferation by a nonspecific factor produced by the Burkitt lymphoma-derived lymphoblast cell line.

Authors:  J J Lightbody; W D Peterson; M D Poulik
Journal:  In Vitro       Date:  1978-05

5.  Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. I. Negative selection across H-2 barriers induced with disrupted cells but not with glutaraldehyde-treated cells: evidence for antigen processing.

Authors:  R Korngold; J Sprent
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

6.  Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide.

Authors:  P S Esquivel; N R Rose; Y C Kong
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.